Ignite Creation Date:
2024-05-06 @ 8:20 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06344208
Status:
RECRUITING
Last Update Posted:
2024-04-03
First Post:
2024-03-27
Brief Title:
Predicting Toxicity in Elderly Patients With Head and Neck Cancer
Sponsor:
European Institute of Oncology
Organization:
European Institute of Oncology
Study Overview
Official Title:
Predicting Toxicity in Elderly Patients With Head and Neck Cancer Validating a Disease-oriented Toxicity Predictive Tool and Integrating it With Available Screening Tools for Better Outcomes
Status:
RECRUITING
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PREtoxEL
Brief Summary:
Predicting toxicity in elderly patients with head and neck cancer
validating a disease-oriented toxicity predictive tool and integrating it with avail-able screening tools for better outcomes
validating a disease-oriented toxicity predictive tool and integrating it with avail-able screening tools for better outcomes
Detailed Description:
We aim to analyze clinical and biochemical variables to prospectively create and validate an independ-ent predictive score to identify the probability of G3-5 toxicity in HNC elderly patients candidated to a curative treatment with radiation treatment - systemic treatment
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None